Revolution Medicines Inc. (RVMD) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Revolution Medicines Inc.

    NASDAQ: RVMD · Real-Time Price · USD
    46.71
    1.01 (2.21%)
    At close: Oct 03, 2025, 3:59 PM
    46.70
    -0.02%
    After-hours: Oct 03, 2025, 07:32 PM EDT

    Revolution Medicines Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -12.23 -7.44 -7.72 -9.79
    PEG Ratio
    		 1.69 -0.29 -0.31 -0.19
    PS Ratio
    		 n/a 280.24 54.28 62.35
    PB Ratio
    		 3.24 1.78 2.80 3.04
    P/FCF Ratio
    		 -12.92 -9.06 -8.16 -11.92
    P/OCF Ratio
    		 -13.16 -9.26 -8.56 -12.45
    OCF/S Ratio
    		 n/a -30.27 -6.34 -5.01
    Debt / Equity Ratio
    		 0.06 0.05 0.09 0.11
    Quick Ratio
    		 14.20 13.06 10.65 9.77
    Current Ratio
    		 14.20 13.06 10.65 9.77
    Asset Turnover
    		 n/a 0.01 0.04 0.04
    Interest Coverage
    		 n/a n/a n/a -15.67K
    Return on Equity
    		 -0.26 -0.24 -0.36 -0.31
    Return on Assets
    		 -0.23 -0.21 -0.31 -0.25
    Return on Invested Capital
    		 -0.29 -0.25 -0.34 -0.27
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a -34.51 -6.15 -5.36
    Net Profit Margin
    		 n/a -37.68 -7.03 -6.37
    Pretax Profit Margin
    		 n/a -37.99 -7.04 -6.37
    Operating Profit Margin
    		 n/a -42.07 -7.3 -6.4
    FCF Margin
    		 n/a -30.94 -6.65 -5.23
    EBITDA Margin
    		 n/a -39.44 -7.03 -6.12

    Add to Watchlist